GWPH News and Press, GW Pharmaceuticals Plc From 05/29/19

CannabisNewsWire Editorial Coverage : Fueled by an explosion of CBD-infused edibles, billion-dollar projections for the CBD market may even be conservative. This seems possible when one considers the truly innovative work being done in the sector by the likes of Lexaria Bioscience Corp. (C...

This week we focus on 50 cannabis companies for which we, as portfolio managers, capture comprehensive investor-related data. We show how we capture the data and apply it to a proprietary algorithm to generate decision-support information. We will let the data speak for itself. But new reade...

The green rush is nothing new to investors that have been following developments over the last few years. As legalization across the nation continues to grow and with mounting pressure on the federal government to move towards legalization, stigma towards cannabis is diminishing at an increasi...

Biotech Pulse The Nasdaq Biotech ( IBB ) and the S&P Biotech ( XBI ) indexes have struggled since March as the broader healthcare sector ( XLV ) declined following growing momentum amongst the presidential candidates for a universal healthcare plan. This was at a time when the broader ma...

STATnews reports that the rapidly growing cannabidiol (CBD) industry, expected to balloon to over $1.3B in three years, is creating headaches for lawmakers and the FDA. More news on: GW Pharmaceuticals plc, ETFMG Alternative Harvest ETF, Global X Fertilizers/Potash ETF, Healthcare stocks...

LONDON, May 09, 2019 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc and its U.S. subsidiary Greenwich Biosciences Inc. (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today announced that Ju...

CannabisNewsWire Editorial Coverage : The growth of vaping has led to the emergence of a new sector. Vaping is tied to the tobacco and cannabis industries but has become popular as a healthier delivery system for both products. Investment and mergers are fueling the industry’s ...

HENDERSON, NV / ACCESSWIRE / May 8, 2019 / If you're a canna-investor and haven't been under a rock, you've probably heard Aurora Cannabis just invested $10 million in EnWave for their vacuum tech which will help improve the potency and flavor of Aurora's crop. Aurora isn't the only produce...

GW Pharmaceuticals (NASDAQ:GWPH) is on the climb after the company reported positive Q1 results and news regarding its famed drug Epidiolex. With shares on the move over the last 7 days, the company is now sitting on weekly gains of 10%. At the time of writing, GWPH stock is tradin...

Catalyst Pharmaceuticals ( CPRX ) - As I'm writing this, the stock has lost 40% of its value in a single day after news came that the FDA approved Ruzurgi from Jacobus Pharma for LEMS (Lambert-Eaton myasthenic syndrome) patients age six to less than 17 years of age. This is the first app...